600056 中国医药
已收盘 09-18 15:00:00
资讯
新帖
简况
广药集团李小军：中国医药企业出海，正从“产品输出”转向“生态协同”
凤凰网港股 · 09-16 12:07
广药集团李小军：中国医药企业出海，正从“产品输出”转向“生态协同”
中国医药：9月11日召开业绩说明会，投资者参与
证券之星 · 09-15
中国医药：9月11日召开业绩说明会，投资者参与
每周股票复盘：中国医药（600056）获业绩补偿款10,120.95万元
证券之星 · 09-13
每周股票复盘：中国医药（600056）获业绩补偿款10,120.95万元
中国医药（600056）披露聘任董事会秘书公告，9月8日股价上涨1.33%
证券之星 · 09-08
中国医药（600056）披露聘任董事会秘书公告，9月8日股价上涨1.33%
每周股票复盘：中国医药（600056）董秘变更由董事长代行职责
证券之星 · 09-06
每周股票复盘：中国医药（600056）董秘变更由董事长代行职责
股市必读：中国医药新发布《关于董事会秘书离任的公告》
证券之星 · 09-03
股市必读：中国医药新发布《关于董事会秘书离任的公告》
中国医药（600056）披露董事会秘书离任公告，9月1日股价上涨0.44%
证券之星 · 09-01
中国医药（600056）披露董事会秘书离任公告，9月1日股价上涨0.44%
中国医药步入黄金时代
证券市场周刊 · 09-01
中国医药步入黄金时代
每周股票复盘：中国医药（600056）股东户数下降3.43%，中报净利降15.26%
证券之星 · 08-30
每周股票复盘：中国医药（600056）股东户数下降3.43%，中报净利降15.26%
中国医药（600056）2026年中报简析：净利润同比下降15.26%
证券之星 · 08-27
中国医药（600056）2026年中报简析：净利润同比下降15.26%
股市必读：中国医药中报 - 第二季度单季净利润同比下降44.88%
证券之星 · 08-27
股市必读：中国医药中报 - 第二季度单季净利润同比下降44.88%
图解中国医药中报：第二季度单季净利润同比下降44.88%
证券之星 · 08-26
图解中国医药中报：第二季度单季净利润同比下降44.88%
股市必读：中国医药（600056）8月18日董秘有最新回复
证券之星 · 08-19
股市必读：中国医药（600056）8月18日董秘有最新回复
中国医药：构建“小通智慧云药房”
证券之星 · 08-18
中国医药：构建“小通智慧云药房”
股市必读：中国医药（600056）8月17日董秘有最新回复
证券之星 · 08-18
股市必读：中国医药（600056）8月17日董秘有最新回复
每周股票复盘：中国医药（600056）子公司获氨甲环酸片上市许可
证券之星 · 08-16
每周股票复盘：中国医药（600056）子公司获氨甲环酸片上市许可
股市必读：中国医药新发布《关于子公司获得药品补充申请批准通知书的公告》
证券之星 · 08-12
股市必读：中国医药新发布《关于子公司获得药品补充申请批准通知书的公告》
中国医药（600056）披露子公司获得药品补充申请批准通知书，8月10日股价上涨0.74%
证券之星 · 08-10
中国医药（600056）披露子公司获得药品补充申请批准通知书，8月10日股价上涨0.74%
股市必读：中国医药新发布《关于子公司参加第十二批全国药品集中采购拟中选的公告》
证券之星 · 08-05
股市必读：中国医药新发布《关于子公司参加第十二批全国药品集中采购拟中选的公告》
股市必读：中国医药新发布《关于子公司参加第十二批全国药品集中采购拟中选的公告》
证券之星 · 08-04
股市必读：中国医药新发布《关于子公司参加第十二批全国药品集中采购拟中选的公告》
加载更多
公司概况
公司名称：
中国医药健康产业股份有限公司
所属行业：
批发业
上市日期：
1997-05-15
主营业务：
中国医药健康产业股份有限公司的主营业务是医药领域的生产、加工和贸易。公司的主要产品是医药研发、医药工业、医药商业、医疗器械、国际贸易、中药大健康、电商业务。报告期内，公司入选药智网“2026化药研发实力TOP100”第72位。
发行价格：
7.02
{"stockData":{"symbol":"600056","market":"SH","secType":"STK","nameCN":"中国医药","latestPrice":8.94,"timestamp":1789714801000,"preClose":8.91,"halted":0,"volume":5574866,"delay":0,"changeRate":0.0034,"floatShares":1495000000,"shares":1496000000,"eps":0.2864,"marketStatus":"已收盘","change":0.03,"latestTime":"09-18 15:00:00","open":8.91,"high":8.98,"low":8.91,"amount":49852100,"amplitude":0.0079,"askPrice":8.94,"askSize":81,"bidPrice":8.93,"bidSize":1571,"shortable":0,"etf":0,"ttmEps":0.2864,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":5,"adr":0,"adjPreClose":8.91,"symbolType":"stock","openAndCloseTimeList":[[1789695000000,1789702200000],[1789707600000,1789714800000]],"highLimit":9.8,"lowLimit":8.02,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1495879748,"isCdr":false,"pbRate":1.12,"roa":"--","peRate":31.215084,"roe":"2.08%","epsLYR":0.3164,"committee":-0.20439,"marketValue":13373000000,"turnoverRate":0.0037,"status":0,"floatMarketCap":13368000000},"requestUrl":"/m/hq/s/600056","defaultTab":"news","newsList":[{"id":"2667467425","title":"广药集团李小军：中国医药企业出海，正从“产品输出”转向“生态协同”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667467425","media":"凤凰网港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667467425?lang=zh_cn&edition=full","pubTime":"2026-09-16 12:07","pubTimestamp":1789531649,"startTime":"0","endTime":"0","summary":"广州医药集团党委书记、董事长李小军出席论坛，并发表主题演讲。李小军表示，当下全球健康产业格局正深刻重塑，中国医药企业的出海模式也正经历从产品输出向生态协同的深度迭代。过去讲出海，更多是把产品卖到全球。但现在，中国医药产业规模已稳居世界第二，在研新药管线约占全球三成，一线创新药研发正从跟跑走向并跑。只靠单品输出，已经不足以支撑真正的全球化，李小军给出的方向是生态出海。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://original.ifeng.com/c/8wSoePaEkdG","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","BK0082","BK0010","BK0175","BK0028","600056","BK0185","BK0188","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667616875","title":"中国医药：9月11日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667616875","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667616875?lang=zh_cn&edition=full","pubTime":"2026-09-15 13:07","pubTimestamp":1789448833,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月14日中国医药发布公告称公司于2026年9月11日召开业绩说明会。现在半年度业绩披露，营业收入只有170亿。2026年上半年，公司深入践行乡村振兴战略，立足武川中药材资源，推动帮扶由“输血”转向长效“造血”。中国医药主营业务：国际贸易业务,医药商业业务,医疗器械业务,医药工业业务,大健康和电商业务。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500018110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0250","BK0175","600056","BK0185","BK0028","03069","BK0082","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667003455","title":"每周股票复盘：中国医药（600056）获业绩补偿款10,120.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667003455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667003455?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:00","pubTimestamp":1789239631,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，中国医药报收于8.91元，较上周的9.06元下跌1.66%。本周，中国医药9月8日盘中最高价报9.18元。本周关注点公司公告汇总：中国医药收到业绩补偿款本息合计10,120.95万元。公司公告汇总中国医药健康产业股份有限公司于2026年9月7日召开第十届董事会第7次会议，审议通过聘任张琳女士为公司董事会秘书，任期自董事会决议通过之日起至第十届董事会届满。案件判决已生效并进入执行阶段，涉案金额为13,940.41万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600056","03069","BK0188","BK0175","BK0028","BK0082","BK0185","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665032189","title":"中国医药（600056）披露聘任董事会秘书公告，9月8日股价上涨1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665032189","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665032189?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:57","pubTimestamp":1788861455,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，中国医药报收于9.17元，较前一交易日上涨1.33%，最新总市值为137.17亿元。中国医药健康产业股份有限公司于2026年9月7日召开第十届董事会第7次会议，审议通过聘任张琳女士为公司董事会秘书，任期自董事会决议通过之日起至第十届董事会届满。公司已就本次聘任向上海证券交易所完成备案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","600056","BK0082","03069","BK0175","BK0185","BK0250","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366324","title":"每周股票复盘：中国医药（600056）董秘变更由董事长代行职责","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366324?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:14","pubTimestamp":1788635652,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，中国医药报收于9.06元，较上周的9.28元下跌2.37%。本周，中国医药8月31日盘中最高价报9.27元。本周关注点公司公告汇总：董事会秘书袁精华因工作调整辞职，辞职后继续担任公司副总经济师，由董事长代行董事会秘书职责。其辞职自送达董事会之日起生效。截至公告日，袁精华先生未持有公司股票，不存在未履行完毕的公开承诺。公司董事会对袁精华先生在任职期间所作贡献表示感谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","BK0028","BK0250","BK0010","BK0188","BK0175","600056","BK0185","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664456128","title":"股市必读：中国医药新发布《关于董事会秘书离任的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664456128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664456128?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:01","pubTimestamp":1788372080,"startTime":"0","endTime":"0","summary":"公司公告汇总关于董事会秘书离任的公告中国医药董事会于2026年9月1日收到董事会秘书袁精华的书面辞职函，其因工作调整申请辞去该职务，辞职自送达董事会之日起生效；辞职后袁精华继续担任公司副总经济师；截至公告日，其未持有公司股票，无未履行完毕的公开承诺；董事会秘书空缺期间，由公司董事长代行相关职责。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600056","03069","BK0082","BK0250","BK0185","BK0175","BK0188","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857989","title":"中国医药（600056）披露董事会秘书离任公告，9月1日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664857989?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:42","pubTimestamp":1788273740,"startTime":"0","endTime":"0","summary":"近日，中国医药健康产业股份有限公司发布《关于董事会秘书离任的公告》。公告显示，公司董事会于2026年9月1日收到董事会秘书袁精华先生的书面辞职函，因工作调整原因，袁精华先生申请辞去公司董事会秘书职务，辞职后将继续担任公司副总经济师。其辞职自送达董事会之日起生效。截至公告日，袁精华先生未持有公司股票，不存在未履行完毕的公开承诺。公司董事会对袁精华先生在任职期间所作贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","BK0082","BK0188","BK0175","BK0028","BK0185","BK0250","BK0010","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664882099","title":"中国医药步入黄金时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2664882099","media":"证券市场周刊","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664882099?lang=zh_cn&edition=full","pubTime":"2026-09-01 10:16","pubTimestamp":1788228975,"startTime":"0","endTime":"0","summary":"七月以来，A股生物医药板块迅速走强。与前几次创新药一枝独秀不同，本轮行情呈现创新药与CXO“双星闪耀”态势，多只个股创近五年股价新高。这得益于企业基本面改善、估值修复、地缘风险缓释及政策利好的叠加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013861234285.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013861234285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0185","600056","BK0175","BK0028","03069","BK0082","BK0010","BK0250","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043115","title":"每周股票复盘：中国医药（600056）股东户数下降3.43%，中报净利降15.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043115","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663043115?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:08","pubTimestamp":1788048497,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，中国医药报收于9.28元，较上周的9.2元上涨0.87%。本周，中国医药8月26日盘中最高价报9.5元。中国医药当前最新总市值138.82亿元，在医药商业板块市值排名6/32，在两市A股市值排名1368/5211。本周关注点股本股东变化：股东户数较上期减少3.43%，户均持股上升至1.2万股。第二季度单季主营收入87.63亿元，同比上升2.51%；单季归母净利润6691.42万元，同比下降44.88%；单季扣非净利润5316.83万元，同比下降43.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0185","BK0175","BK0028","600056","03069","BK0082","BK0188","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740312","title":"中国医药（600056）2026年中报简析：净利润同比下降15.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740312","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662740312?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:02","pubTimestamp":1787781737,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期中国医药发布2026年中报。根据财报显示，中国医药净利润同比下降15.26%。截至本报告期末，公司营业总收入169.52亿元，同比下降0.73%，归母净利润2.49亿元，同比下降15.26%。按单季度数据看，第二季度营业总收入87.63亿元，同比上升2.51%，第二季度归母净利润6691.42万元，同比下降44.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749516","title":"股市必读：中国医药中报 - 第二季度单季净利润同比下降44.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662749516?lang=zh_cn&edition=full","pubTime":"2026-08-27 02:20","pubTimestamp":1787768423,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润6691.42万元，同比下降44.88%。业绩披露要点财务报告2026年中报显示，上半年度主营收入169.52亿元，同比下降0.73%；归母净利润2.49亿元，同比下降15.26%；扣非净利润2.31亿元，同比下降9.81%；第二季度单季度主营收入87.63亿元，同比上升2.51%；单季度归母净利润6691.42万元，同比下降44.88%；单季度扣非净利润5316.83万元，同比下降43.65%；负债率62.69%，投资收益1252.66万元，财务费用1.25亿元，毛利率10.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700006817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662465759","title":"图解中国医药中报：第二季度单季净利润同比下降44.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662465759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662465759?lang=zh_cn&edition=full","pubTime":"2026-08-26 01:40","pubTimestamp":1787679645,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药2026年中报显示，上半年度公司主营收入169.52亿元，同比下降0.73%；归母净利润2.49亿元，同比下降15.26%；扣非净利润2.31亿元，同比下降9.81%；其中2026年第二季度，公司单季度主营收入87.63亿元，同比上升2.51%；单季度归母净利润6691.42万元，同比下降44.88%；单季度扣非净利润5316.83万元，同比下降43.65%；负债率62.69%，投资收益1252.66万元，财务费用1.25亿元，毛利率10.86%。财报数据概要请见下图:本文数据来源于中国医药2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600004235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600056","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491288","title":"股市必读：中国医药（600056）8月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491288?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:55","pubTimestamp":1787079311,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，中国医药报收于9.44元，下跌0.63%，换手率0.88%，成交量13.22万手，成交额1.25亿元。董秘最新回复投资者： 要推动科技创新成果在卫生健康领域转化运用，推进全民健康数智化建设。请问公司在科技创新和健康数智化建设做了什么工作董秘： 您好！公司将结合自身业务实际，稳步推动科技创新成果转化与数智化转型升级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","600056","BK0185","BK0028","BK0175","BK0188","BK0250","BK0010","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660463135","title":"中国医药：构建“小通智慧云药房”","url":"https://stock-news.laohu8.com/highlight/detail?id=2660463135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660463135?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:57","pubTimestamp":1787043439,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药08月18日在投资者关系平台上答复投资者关心的问题。请问公司在科技创新和健康数智化建设做了什么工作中国医药回复：您好！公司构建“小通智慧云药房”，提供云找药、互联网医院、健康管理等线上服务，同时扎实推进“数智穿透监管”与“AI+提效”两大工程。公司将结合自身业务实际，稳步推动科技创新成果转化与数智化转型升级。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800029033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","BK0250","BK0010","BK0185","BK0188","BK0082","BK0175","BK0028","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431040","title":"股市必读：中国医药（600056）8月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660431040?lang=zh_cn&edition=full","pubTime":"2026-08-18 02:21","pubTimestamp":1786990869,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，中国医药报收于9.5元，下跌0.31%，换手率1.45%，成交量21.72万手，成交额2.05亿元。董秘最新回复投资者： 通用技术中国医药2026医药融合创新研讨会，请问公司邀请人来研讨，面对提问会回答吗？当日关注点交易信息汇总：8月17日主力资金净流出41.19万元，游资资金净流出1250.57万元，散户资金净流入1291.76万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800002311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0010","BK0188","600056","BK0185","BK0082","03069","BK0250","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659176884","title":"每周股票复盘：中国医药（600056）子公司获氨甲环酸片上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2659176884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659176884?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:33","pubTimestamp":1786818790,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，中国医药报收于9.53元，较上周的9.4元上涨1.38%。本周关注点来自公司公告汇总：子公司天方药业获批氨甲环酸片上市许可持有人变更。公司公告汇总中国医药全资子公司天方药业有限公司收到国家药监局核准签发的氨甲环酸片《药品补充申请批准通知书》，同意该药品上市许可持有人由浙江兄弟药业有限公司变更为天方药业有限公司。截至目前，国内已有包括天方药业在内的18家生产企业获得该药品批件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","600056","BK0175","BK0028","BK0250","03069","BK0188","BK0082","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658125299","title":"股市必读：中国医药新发布《关于子公司获得药品补充申请批准通知书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658125299","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658125299?lang=zh_cn&edition=full","pubTime":"2026-08-12 00:59","pubTimestamp":1786467548,"startTime":"0","endTime":"0","summary":"公司公告汇总关于子公司获得药品补充申请批准通知书的公告中国医药全资子公司天方药业有限公司收到国家药监局核准签发的氨甲环酸片《药品补充申请批准通知书》，同意该药品上市许可持有人由浙江兄弟药业有限公司变更为天方药业有限公司。截至目前，国内已有包括天方药业在内的18家生产企业获得该药品批件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0250","600056","BK0188","BK0010","BK0175","BK0082","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658378309","title":"中国医药（600056）披露子公司获得药品补充申请批准通知书，8月10日股价上涨0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658378309","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658378309?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:35","pubTimestamp":1786372517,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，中国医药报收于9.47元，较前一交易日上涨0.74%，最新总市值为141.66亿元。近日，中国医药全资子公司天方药业有限公司收到国家药监局核准签发的氨甲环酸片《药品补充申请批准通知书》，同意该药品上市许可持有人由浙江兄弟药业有限公司变更为天方药业有限公司。截至目前，国内已有包括天方药业在内的18家生产企业获得该药品批件。2025年该药品在中国三大终端六大市场销售额约为27,128万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0175","600056","BK0185","BK0250","BK0028","BK0188","BK0082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657339565","title":"股市必读：中国医药新发布《关于子公司参加第十二批全国药品集中采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657339565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657339565?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:33","pubTimestamp":1785868390,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，中国医药报收于9.48元，下跌0.94%，换手率0.91%，成交量13.57万手，成交额1.3亿元。公司公告汇总：中国医药下属四家子公司参与第十二批全国药品集采，盐酸倍他司汀片等8个产品拟中选，采购周期为3年。若最终中标并签订合同，将有利于扩大销售规模，提升市场占有率和品牌影响力。目前采购协议尚未签订，存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0010","BK0188","BK0185","BK0175","BK0028","BK0082","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656303280","title":"股市必读：中国医药新发布《关于子公司参加第十二批全国药品集中采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656303280","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656303280?lang=zh_cn&edition=full","pubTime":"2026-08-04 01:05","pubTimestamp":1785776714,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，中国医药报收于9.57元，上涨0.1%，换手率0.74%，成交量11.03万手，成交额1.06亿元。公司公告汇总：下属四家子公司参与第十二批全国药品集采，盐酸倍他司汀片等8个产品拟中选，采购周期为3年。若最终中标并签订合同，将有利于扩大销售规模，提升市场占有率和品牌影响力。目前采购协议尚未签订，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600056","BK0028","BK0175","BK0010","BK0185","BK0188","BK0250","BK0082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789740660394,"stockEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":-0.0561},{"period":"3month","weight":-0.0113},{"period":"6month","weight":-0.1207},{"period":"1year","weight":-0.1779},{"period":"ytd","weight":-0.1301}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":-0.0287},{"period":"3month","weight":-0.0525},{"period":"6month","weight":-0.0206},{"period":"1year","weight":-0.0002},{"period":"ytd","weight":-0.0235}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"中国医药健康产业股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"124580人(较上一季度减少3.43%)","perCapita":"12003股","listingDate":"1997-05-15","address":"北京市丰台区西营街1号院1区1号楼25-28层","registeredCapital":"149587万元","survey":" 中国医药健康产业股份有限公司的主营业务是医药领域的生产、加工和贸易。公司的主要产品是医药研发、医药工业、医药商业、医疗器械、国际贸易、中药大健康、电商业务。报告期内，公司入选药智网“2026化药研发实力TOP100”第72位。","listedPrice":7.02},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国医药,600056,中国医药股票,中国医药股票老虎,中国医药股票老虎国际,中国医药行情,中国医药股票行情,中国医药股价,中国医药股市,中国医药股票价格,中国医药股票交易,中国医药股票购买,中国医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}